Spontaneous Urticaria
📧 Sign up to get email alerts when something new happens for Spontaneous Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of MG-K10 in Chronic Spontaneous Urticaria [Phase 3]
This is an update on a Phase 3 clinical trial evaluating MG-K10 for chronic spontaneous urticaria, which is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria [Phase 2, Phase 3]
An ongoing Phase 2/3 clinical trial evaluating the efficacy and safety of ICP-332 in people with chronic spontaneous urticaria; recruitment …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of EDP-978 in healthy adu…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Remibrutinib in Real-world Clinical Practice
An update indicates that a real-world clinical trial of remibrutinib for chronic spontaneous urticaria is currently recruiting, sponsored by…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up [Phase 3]
Phase 3, double-blind, randomized, placebo-controlled trial to assess the efficacy, pharmacokinetics, and safety of LOU064 in adolescents (1…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
This study aims to describe real-world effectiveness, safety, and patterns of use of dupilumab in patients with chronic spontaneous urticari…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. [Phase 2]
Pfizer is conducting a Phase 2 trial to evaluate ritlecitinib as a potential treatment for chronic spontaneous urticaria in adults; the stud…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) [Phase 2]
A Phase 2 clinical trial evaluating CM512 injection for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria [Phase 3]
A Phase 3 long-term efficacy and safety extension study of Barzolvolimab for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of remibrutinib (LOU064) in chronic urticaria, including chronic spontaneous …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) [Phase 3]
This update notes that a Phase 3 trial of Barzolvolimab for chronic spontaneous urticaria is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. [Phase 3]
This document describes a Phase 3b trial evaluating remibrutinib versus placebo with omalizumab as an active control in adults with chronic …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
A real-world study evaluating remibrutinib for chronic spontaneous urticaria, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
This ClinicalTrials.gov entry describes an observational study evaluating Omlyclo®, an omalizumab biosimilar, in patients with chronic spont…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) [Phase 2]
BLU-808 is being studied in a Phase 2 trial for Chronic Inducible Urticaria and Chronic Spontaneous Urticaria, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Remibrutinib in Real-world Clinical Practice - a US Sub-study
A US sub-study of real-world clinical practice evaluating remibrutinib for chronic spontaneous urticaria is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria [Phase 1]
Phase 1 study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-ascending doses of BGB-16673 in adults with…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Analysis of the Role of IgE Proteoforms in Health and Disease
KU Leuven is updating on a clinical trial studying the role of IgE proteoforms in health and disease, with recruitment ongoing across severa…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Real-world study evaluating how to intensify omalizumab treatment for chronic spontaneous urticaria.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of Single Dose of LP-003 in Healthy Adult Subjects [Phase 1]
Phase 1 study evaluating a single dose of LP-003 in healthy adults. The trial status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria
Global managed access program update for remibrutinib in adults with chronic spontaneous urticaria; program is currently available.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and the food effect of single and multiple doses of HRS-…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria [Phase 3]
Phase 3 study comparing CMAB007 to Xolair (omalizumab) for chronic spontaneous urticaria is currently recruiting. The trial aims to evaluate…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria [Phase 4]
Phase 4 clinical trial updating on extending omalizumab treatment intervals for chronic spontaneous urticaria; currently recruiting.